gefitinib 250 mg film-coated tablet

What Gefitinib Avansor 250 mg film-coated tablets are and what they are used for

Gefitinib Avansor contains the active substance gefitinib which blocks a protein called epidermal growth factor receptor (EGFR). This protein is involved in the growth and spread of cancer cells.

Gefitinib Avansor is used to treat adults with non-small cell lung cancer. This cancer is a disease in which malignant (cancerous) cells form in the lung tissue.

Gefitinib contained in Gefitinib Advansor may also be approved for the treatment of other conditions not mentioned in this product information. Ask your doctor, pharmacist, or other healthcare professional if you have any further questions, and always follow their instructions.

What you need to know before you use Gefitinib Avansor 250 mg film-coated tablets

Do not use Gefitinib Avansor 250 mg film-coated tablets

  • if you are allergic to gefitinib or any of the other ingredients of this medicine (listed in section 6, “Contents of contents”).
  • if you are breast-feeding

Warnings and cautions

Talk to your doctor or pharmacist before taking Gefitinib Avansor:

  • if you have ever had other lung problems before . Some lung problems may be aggravated by treatment with Gefitinib Avansor.
  • if you have ever had liver problems 

Children and young people

Gefitinib Advance is not intended for use in children and adolescents below 18 years.

Other medicines and Gefitinib Avansor 250 mg film-coated tablets

Tell your doctor or pharmacist if you have recently taken or might take any other medicines.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines:

  • phenytoin or carbamazepine (for epilepsy ).
  • rifampicin (for tuberculosis ).
  • itraconazole (against fungal infections).
  • barbiturate s (a type of medicines for sleep problems).
  • herbal medicines containing St. John’s wort (Hypericum perforatum, which is used for depression and anxiety).
  • proton pump inhibitors , H2- antagonist s and antacids (for gastric ulcer , indigestion, heartburn and to reduce the acid in the stomach).

These medicines may affect the effect of Gefitinib Avansor.

  • Warfarin (a so-called oral anticoagulant to prevent blood clots). If you are taking a medicine containing this active substance, your doctor may need to take blood samples more often.

If any of the above apply to you, or if you are not sure, talk to your doctor or pharmacist before taking Gefitinib Avansor.

Pregnancy, breastfeeding and fertility

If you are pregnant, pregnant, or breastfeeding, ask your doctor for advice before taking this medicine.

It is recommended that you avoid becoming pregnant while being treated with Gefitinib Avansor as Gefitinib Avansor may harm your baby.

For the safety of your baby, do not use Gefitinib Avansor if you are breastfeeding.

Driving and using machines

Should you feel weak while using this medicine, you should be careful when driving or using machines.

You are responsible for assessing whether you are fit to drive a motor vehicle or perform work that requires sharpened attention. One of the factors that can affect your ability in these respects is the use of drugs due to their effects and/or side effects. Descriptions of these effects and side effects can be found in other sections. Read all the information in this leaflet for guidance. If you are not sure, talk to your doctor or pharmacist.

Gefitinib Avansor 250 mg film-coated tablets contain excipients

Gefitinib Avansor  contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

Gefitinib Avansor contains croscarmellose sodium and sodium lauryl sulfate

This medicine contains less than 1 mmol (23 mg) sodium per tablet, ie essentially ‘sodium-free. is next to “sodium-free”.

How to use Gefitinib Avansor 250 mg film-coated tablets

Always take this medicine exactly as your doctor has told you. Ask your doctor or pharmacist if you are unsure.

  • The recommended dose is 1 tablet (250 mg) daily.
  • Take the tablet at about the same time each day.
  • You can take the tablet with or without food.
  • Do not take antacids (to reduce the amount of acid in your stomach) 2 hours before or 1 hour after taking Gefitinib Avansor.

If you have problems swallowing the tablet, you can dissolve it in half a glass of water that does not contain carbon dioxide. Do not use any other liquid. Do not crush the tablet. Swirl the glass until the tablet has dissolved. This can take up to 20 minutes. Then drink the liquid immediately. To be sure that you have ingested all the medicine, rinse the glass very thoroughly with half a glass of water and drink from it.

If you use more Gefitinib Avansor 250 mg film-coated tablets than you should 

If you have ingested too much medicine or if e.g. If a child has ingested the medicine by mistake, contact a doctor, hospital, or the Poison Information Center for risk assessment and advice.

If you forget to use Gefitinib Avansor 250 mg film-coated tablets

What to do if you forget to take a tablet depends on how much time is left until the next dose.

  • If it is 12 hours or more until the next dose: take the forgotten tablet as soon as you remember that you forgot it. Then take the next dose at the usual time.
  • If it is less than 12 hours until you take the next dose: skip the missed dose . Then take the next dose at the usual time.

Do not take a double dose (two doses at the same time) to compensate for a missed dose.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact your doctor immediately if you get any of the following side effects – you may need immediate medical attention:

  • Allergic reaction (common) especially if the symptoms include swelling of the face, lips, tongue or throat, difficulty swallowing, hives, hives and difficulty breathing.
  • Severe shortness of breath, or sudden worsening of shortness of breath and possibly also cough and fever. This may mean that you have an inflammation of the lungs called “interstitial lung disease”. It affects approximately 1 in 100 patients taking Gefitinib Avansor and may be life-threatening.
  • Severe skin reactions (rare) that affect large areas of the body. Signs of this can be redness , pain, sores, blisters and flaking of the skin. Lips, nose, eyes and genitals can also be affected.
  • Dehydration (common) caused by prolonged or severe diarrhea, vomiting, nausea or loss of appetite.
  • Eye problems (rare) such as pain, red eyes, watery eyes, photosensitivity, changes in vision or that the eyelashes grow inwards. This may mean that you have a wound on the surface of the eye (cornea).

Talk to your doctor as soon as possible if you get any of the following side effects:

Very common (may affect more than 1 user in 10)

  • Loss of appetite
  • Diarrhea
  • Vomiting
  • Nausea
  • Red or sore mouth
  • Skin reactions, such as acne-like rashes that sometimes itch and include dry and / or cracked skin
  • Weakness
  • Elevation of the liver enzyme alanine aminotransferase in blood samples; if too high, your doctor may urge you to stop taking Gefitinib Advances

Common (may affect up to 1 in 10 people)

  • Dry mouth
  • Dry, red or itchy eyes
  • Red and sore eyelids
  • Nail problems
  • Hair loss
  • Fever
  • Bleeding (eg nosebleeds or blood in the urine)
  • Elevation of bilirubin and liver enzyme aspartate aminotransferase in blood tests; if too high, your doctor may urge you to stop taking Gefitinib Advances
  • Increased levels of creatinine in blood tests (shows how your kidneys are working), protein in the urine (seen in urine tests)
  • Cystitis (burning sensation when urinating and frequent, acute urges)

Uncommon (may affect up to 1 in 100 people)

  • Inflammation of the pancreas. It is characterized by very severe pain in the upper abdomen and severe nausea and vomiting.
  • Holes ( perforation are) in the gastrointestinal tract
  • Inflammation of the liver. The symptoms may be a general feeling of illness with or without any jaundice (the skin and whites of the eyes turn yellow). This side effect is less common, but some patients have died from it.

Rare (may affect up to 1 in 1,000 people)

  • Inflammation of the blood vessels in the skin. It may look like bruises or blemishes on the skin that do not fade away.
  • Hemorrhagic cystitis (burning sensation when urinating and frequent, acute urination with blood in the urine)

Reporting of side effects ar 

If you get any side effects, talk to your doctor, pharmacist, or nurse. This also applies to any side effects not mentioned in this information. You can also report side effects directly (see details below). By reporting side effects, you can help increase the safety of medicines.

Box 26
751 03

5. How to store Gefitinib Avansor 250 mg film-coated tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiration date is the last day of the specified month.

No special storage instructions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Contents of the packaging and other information

Content declaration

  • The active substance is gefitinib. Each tablet contains 250 mg of gefitinib.
  • The other ingredients (excipients) are sodium lauryl sulphate , lactose monohydrate , microcrystalline cellulose, povidone, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, macrogol, talc, red iron oxide (E172), yellow iron oxide (E172) and black iron oxide.

What the medicine looks like and contents of the pack

Gefitinib Avansor brown, round, biconvex coated tablets (about 11 mm in diameter) marked with G9FB 250 on one side.

Gefitinib Avansor is supplied in blister packs of 30 tablets or 30 x 1 tablets. The blister foil may be perforated or unperforated.

Not all pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorisation Holder

Avansor Pharma Oy

Technician 14

02150 Espoo



Synthon Hispania SL

Castelló 1, Polígono Las Salinas

08830 Sant Boi de Llobregat



Synthon BV

Microweg 22

6545 CM



Muhammad Nadeem

Leave a Reply